The following excerpt is from the company's SEC filing.
Dec. 10, 2020 (GLOBE NEWSWIRE) -- via InvestorWire –
Corp. (OTCQB: CNSC)
, a biotechnological pharmaceutical and wellness company marketing the
Xceptol consumer brand, today announces it has selected the corporate communications expertise of the
a multifaceted financial news and publishing company for private and public entities.
CannAssist is the owner
of Xceptor Labs, an R&D and raw material manufacturing outfit leveraging its proprietary CiBiDinol technology to create CBD
products that it bel ieves have better absorption than currently marketed oil-based products. CiBiDinol is believed to provide CBD
in a format that is more in line with the body’s natural bioactivity. It is specifically designed to address many critical
issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life, while offering more predictable
potency and enabling reduced dosage requirements.
of the Client Partner relationship with CannAssist, IBN will leverage its investor based distribution network of
key syndication outlets
, wire services via
blogs and other outreach tools to generate greater awareness for
“We are pleased
to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,”
states Mark Palumbo, CEO of CannAssist.
years of experience assisting
500+ client partners
communications within the investment community, and a sizable family of
, IBN has amassed a collective audience that includes
of social media followers
. IBN is uniquely positioned to provide CannAssist the solutions
needed to reach a wide audience of investors, consumers, journalists and the general public.
cannabidiol market has been on fire since the 2018 Farm Bill was signed into law. In 2018, the global CBD market was valued at
$4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to
. CannAssist is uniquely positioned to capitalize on this market growth,”
states Chris Johnson, Director of Client Solutions for IBN. “Based on current revenue from raw material sales, retail sales
and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million. We’re
excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product
pipeline and achieve steady sales growth in the years ahead.”
more about CannAssist, visit the company's corporate newsroom profile at
and sells its cannabidiol (“CBD”) product, ‘CiBiDinol’, which is formulated based on a proprietary process
developed by its founder, Mark Palumbo. CBD is a non-psychoactive compound found in hemp. CannAssist's initial research and development
work, aimed at enhancing the bioavailability of desired molecular structures, resulted in the creation of a line of CBD products,
most notably its CBD product, CiBiDinol. CiBiDinol will be available in a line of consumable and topical products that the company
believes will make enhanced CBD products more available and accessible to consumers.
information about the company, visit
consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective
audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing
base of Client Partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge
and energy of specialized teams of experts to serve our increasingly diversified list of clients.
and its affiliate brands, IBN provides: (1) access to a network of wire solutions via
reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication
to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing
social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.
information on IBN visit
This release contains
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations
and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance
on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements,
prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the
company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated
in the forward-looking statements.
Los Angeles, California
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever CANNASSIST INTL CORP. makes a similar move, sign up!
Other recent filings from the company include the following:
TERMINATION OF A MATERIAL DEFINITIVE - Oct. 14, 2021